Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by MPM BioVentures 2014, L.P., Board Member / Venture Capital Investor. Officer active across 5 companies, notably Werewolf Therapeutics, Inc.. In total, 57 disclosures have been published. Breakdown: 0 buy · 49 sells. Total volume traded: €29.6m. History available since 7 September 2021. The latest transaction was filed on 26 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to MPM BioVentures 2014, L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17,569 shares@ US$34.684.0% of flowCommon StockSEC:0001209191-21-068408:0
25 of 57 declarations
About MPM BioVentures 2014, L.P.
MPM BioVentures 2014, L.P. is a Board Member / Venture Capital Investor. The record shows 31 filings in total, and the 31 sampled filings between 2021-05-06 and 2025-12-04 show only sales, with EUR 14738753 in sells and EUR 0 in buys. The companies involved include iTeos Therapeutics, Inc., Werewolf Therapeutics, Inc., Entrada Therapeutics, Inc., and TCR2 THERAPEUTICS INC.